Literature DB >> 1516900

Clinical review of clozapine treatment in a state hospital.

W H Wilson1.   

Abstract

Medical records of the first 37 patients to begin clozapine treatment at a state hospital in Oregon were reviewed for six months before clozapine treatment and six months after. Patients had a long history of schizophrenia and had responded poorly to antipsychotic medication. Clozapine treatment was generally well tolerated, although the rate of seizures (8 percent) was slightly higher than expected. Psychotic symptoms decreased as measured by the Brief Psychiatric Rating Scale, as did symptoms of tardive dyskinesia as measured by the Abnormal Involuntary Movement Scale. Thirty-four patients remained hospitalized after six months of treatment. However, indicators of social function (hospital privilege level, community passes, violent episodes, and episodes of seclusion and restraint) all showed that patients improved markedly after receiving clozapine.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1516900     DOI: 10.1176/ps.43.7.700

Source DB:  PubMed          Journal:  Hosp Community Psychiatry        ISSN: 0022-1597


  13 in total

1.  Clozapine rationing in a state mental hospital: a response to Backlar and McFarland.

Authors:  William H Wilson
Journal:  HEC Forum       Date:  1993-09

2.  Clozapine: an appraisal of its pharmacoeconomic benefits in the treatment of schizophrenia.

Authors:  A Fitton; P Benfield
Journal:  Pharmacoeconomics       Date:  1993-08       Impact factor: 4.981

3.  An open clinical trial with clozapine in treatment-resistant schizophrenics.

Authors:  A K Agarwal; M Sharma; S Srivastava; M Mullick; A Kumar
Journal:  Indian J Psychiatry       Date:  1997-01       Impact factor: 1.759

4.  Cost-benefit analysis of risperidone and clozapine in the treatment of schizophrenia in Israel.

Authors:  G Ginsberg; S Shani; B Lev
Journal:  Pharmacoeconomics       Date:  1998-02       Impact factor: 4.981

5.  Clozapine rationing in a state mental hospital: reviewing a HEC's case consultation.

Authors:  P Backlar; B H McFarland
Journal:  HEC Forum       Date:  1993-09

6.  Addition of lithium to haloperidol in non-affective, antipsychotic non-responsive schizophrenia: a double blind, placebo controlled, parallel design clinical trial.

Authors:  W H Wilson
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  [Atypical antipsychotics in therapy refractory schizophrenia].

Authors:  I Schäfer; M Lambert; D Naber
Journal:  Nervenarzt       Date:  2004-01       Impact factor: 1.214

8.  Clozapine-related EEG changes and seizures: dose and plasma-level relationships.

Authors:  Seema Varma; Delia Bishara; Frank M C Besag; David Taylor
Journal:  Ther Adv Psychopharmacol       Date:  2011-04

9.  Violence and mental illness.

Authors:  Marie E Rueve; Randon S Welton
Journal:  Psychiatry (Edgmont)       Date:  2008-05

10.  Treatment-refractory schizophrenia.

Authors:  Asaf Caspi; Michael Davidson; Carol A Tamminga
Journal:  Dialogues Clin Neurosci       Date:  2004-03       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.